TORONTO and GLIL YAM, Israel

多伦多和以色列格利尔亚姆

,

，

July 1, 2026

2026年7月1日

/PRNewswire/ --

/美通社/ --

IM Cannabis Corp.

IM 大麻公司

('

（'

IMC

集成电路制造

' or the '

' 或 '

Company

公司

') (NASDAQ:

') (纳斯达克：

IMCC

IMCC

), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the '

），一家在以色列和德国开展业务的医用大麻公司，今日宣布完成一笔22.5万美元的可转换票据融资，该融资通过向一名机构投资者（“

Lender

贷款人

').

').

Pursuant to a note purchase agreement between the Company and Lender dated July 1, 2026 (the '

根据本公司与贷款人于2026年7月1日签署的票据购买协议（“

July Note Purchase Agreement

七月票据购买协议

'), the Company issued the Lender a note in the principal amount of US$225,000, with an original issuance discount of 10% (the '

），本公司向贷款人签发了一张本金金额为225,000美元、原始发行折扣为10%的票据（“

July Note

七月笔记

').

').

The July Note bears interest at a rate of 8% per annum, increasing to 14% upon the occurrence and continuation of an event of default, as defined in the July Note. The July Note is not repayable in cash and the Company's obligations thereunder will be satisfied solely through the issuance of common shares in the capital of the Company (the '.

七月票据的年利率为8%，若发生并持续存在七月票据所定义的违约事件，则利率将升至14%。七月票据不得以现金偿还，公司在该票据项下的义务将仅通过发行公司资本中的普通股来履行（“

Common Shares

普通股

') upon conversion.

'）在转换时。

The conversion price in the July Note is set to the lower of (i) a fixed price of US$0.152 per Common Share, or (ii) 90% of the lowest daily volume-weighted average price during the 20 consecutive trading days preceding the conversion date, subject to a floor price of US$0.0303. The July Note includes customary limitations, including a 4.99% beneficial ownership cap..

七月票据的转换价格设定为以下两者中的较低者：(i) 每股普通股0.152美元的固定价格，或 (ii) 转换日前连续20个交易日中每日成交量加权平均价格的最低值的90%，且设有0.0303美元的价格下限。七月票据包含惯常的限制条款，包括4.99%的受益所有权上限。

In connection with the July Note, the Company issued a warrant to purchase up to 1,483,386 Common Shares (the '

就七月票据而言，本公司发行了一份认股权证，允许购买最多1,483,386股普通股（“

July Note Warrants

七月期认股权证

') at an exercise price of C$0.22 per Common Share. The July Note Warrants became immediately exercisable upon their issuance date, July 1, 2026, and will expire after five years, on July 1, 2031.

）以每股普通股0.22加元的行权价。七月票据认股权证自发行日（2026年7月1日）起即可立即行使，并将于五年后，即2031年7月1日到期。

The Company intends to use the net proceeds from the July Note for general corporate purposes.

公司拟将七月票据的净收益用于一般企业用途。

In connection with the July Note Purchase Agreement, the Company has agreed to reserve sufficient Common Shares for issuance upon conversion of the July Note and exercise of the July Note Warrants and to file a resale registration statement on Form F-3 with the U.S. Securities and Exchange Commission (the '.

就七月票据购买协议而言，公司已同意预留足够的普通股股份，以便在七月票据转换及七月票据认股权证行权时发行，并向美国证券交易委员会提交一份F-3表格的转售注册声明。

SEC

美国证券交易委员会

') and to use commercially reasonable efforts to secure its effectiveness within the timeframes agreed with the Lender.

'）并尽商业上合理的努力，在与贷款人约定的时间框架内确保其生效。

All securities issued under the financing described above are subject to: (i) a four month and one day hold period from the date of issuance and (ii) applicable legends as required pursuant to the U.S. Securities Act of 1933, as amended (the '

根据上述融资发行的所有证券均须遵守：(i) 自发行之日起四个月的持有期；以及 (ii) 根据经修订的《1933年美国证券法》（即“

Securities Act

证券法

'). The private placement of the securities offered to the Lender was made in reliance on an exemption from (x) registration under Section 4(a)(2) of the Securities Act and (y) applicable Canadian securities laws. Accordingly, the securities issued in the private placement may not be offered or sold in the United States or Canada except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws or an exemption pursuant to Canadian securities laws..

）。向贷款人提供的证券私募发行是依据以下豁免进行的：(x) 《证券法》第4(a)(2)条规定的注册豁免，以及(y) 适用的加拿大证券法豁免。因此，除非依据有效的注册声明，或依据《证券法》及适用的州证券法关于注册要求的适用豁免，或依据加拿大证券法的豁免，否则不得在美国或加拿大要约或出售该等私募发行的证券。

About IM Cannabis Corp.

关于IM Cannabis Corp.

IMC (Nasdaq:

IMC（纳斯达克：

IMCC

国际海事犯罪中心

) is an international company focused on building and scaling innovative businesses and technologies across global markets. The Company currently operates a medical cannabis platform serving patients in Israel and Germany while evaluating opportunities to expand into additional technology-driven sectors..

）是一家专注于在全球市场建设和扩展创新业务与技术的国际公司。该公司目前运营一个面向以色列和德国患者的医用大麻平台，同时正在评估向其他技术驱动型领域扩张的机会。

The IMC ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies and online platforms, in Israel that enable the safe delivery and quality control of IMC products throughout the entire value chain.

IMC生态系统通过其子公司在以色列运营，这些子公司利用多年积累的专有数据和患者洞察，向医疗患者进口和分销大麻。该公司还在以色列经营医用大麻零售药店和在线平台，确保IMC产品在整个价值链中的安全交付和质量控制。

In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients..

在德国，IMC生态系统通过Adjupharm GmbH运营，向药店分发大麻，供医用大麻患者使用。

Company Contact:

公司联系人：

Michal Efraty

米哈尔·埃夫拉蒂

Investor & Public Relations

投资者与公共关系

IM Cannabis Corp.

IM大麻公司

[email protected]

[email protected]

Oren Shuster, Chief Executive Officer

奥伦·舒斯特，首席执行官

IM Cannabis Corp.

IM 大麻公司

[email protected]

[email protected]

Disclaimer for Forward-Looking Statements

前瞻性陈述免责声明

This press release contains forward-looking information or forward-looking statements under applicable Canadian and United States securities laws (collectively, '

本新闻稿包含根据适用的加拿大和美国证券法律（统称为“

forward-looking statements

前瞻性陈述

'). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as 'seek', 'anticipate', 'believe', 'plan', 'estimate', 'expect', 'likely' and 'intend' and statements that an event or result 'may', 'will', 'should', 'could' or 'might' occur or be achieved and other similar expressions.

）。所有涉及我们预期未来将发生的活动或发展的信息均为前瞻性陈述。前瞻性陈述通常（但并非总是）通过使用“寻求”、“预计”、“相信”、“计划”、“估计”、“预期”、“可能”和“打算”等词语，以及声明某事件或结果“可能”、“将会”、“应该”、“能够”或“或许”发生或实现，以及其他类似表述来识别。

Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to, statements relating to: the receipt of and use of proceeds from the financing and the preparation, timing and filing of the registration statement with the SEC.

前瞻性陈述基于管理层在作出该等陈述之日的估计和意见。在本新闻稿中，此类前瞻性陈述包括但不限于与以下事项相关的陈述：融资所得款项的收取及使用，以及向美国证券交易委员会（SEC）提交注册声明的准备、时间安排及提交事宜。

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward-looking statements due to a number of factors and risks.

上述前瞻性陈述和假设清单并非详尽无遗。由于前瞻性陈述涉及未来事件和状况，其性质本身即包含固有的风险和不确定性。由于多种因素和风险，实际结果可能与当前预期或此类前瞻性陈述所暗示的结果存在重大差异。

These include: the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the Company's ability to continue to meet the listing requirements of the Nasdaq Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and its subsidiaries (collectively, the '.

这些因素包括：公司在高度监管的行业中未能遵守适用的监管要求；公司运营所在司法管辖区的政府政策和法规发生意外变化；公司持续满足纳斯达克资本市场上市要求的能力；任何未能保持良好信誉或更新其许可证的意外情况；公司及其子公司（统称为“

Group

组

') to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group's obligations; the Group's possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group's cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt; risks surrounding war, conflict and civil unrest in Eastern Europe and the Middle East, including the impact of the multi front war Israel is facing on the Company, its operations and the medical cannabis industry in Israel; risks associated with the Company focusing on the Israel and Germany markets; the inability of the Company to achieve sustainable profitability and/or increase shareholder value; the inability of the Company to actively manage costs and/or improve margins; the inability of the company to grow and/or maintain sales; the inability of the Company to meet its goals and/or strategic plans; the inability of the Company to reduce costs and/or maintain revenues; the Company's inability to take advantage of the legalization of medicinal cannabis in Germany; the Company's inability to use the proceeds as set out herein; and the Company's inability to file a registration statement in the timelines outlined here.

）履行其销售承诺或增长目标；集团依赖第三方供应协议以提供足够数量的医用大麻来履行集团义务；集团可能面临的法律责任、与此相关的感知风险水平，以及涉及集团的任何诉讼或其他类似争议或法律程序的预期结果；竞争加剧的影响；缺乏并购机会；不利的市场状况；产量、质量和成本估算固有的不确定性，以及产生意外成本和费用的可能性；因使用集团大麻产品而导致的产品责任及其他安全相关责任的风险；供应链限制；对关键人员的依赖；现有债务违约的风险；与东欧和中东地区的战争、冲突及内乱相关的风险，包括以色列面临的多线战争对公司、其运营以及以色列医用大麻行业的影响；与公司专注于以色列和德国市场相关的风险；公司无法实现可持续盈利和/或提升股东价值；公司无法积极管理成本和/或提高利润率；公司无法增长和/或维持销售额；公司无法实现其目标和/或战略计划；公司无法降低成本和/或维持收入；公司无法利用德国医用大麻合法化的机遇；公司无法按本文所述使用所得款项；以及公司无法在本文规定的时间表内提交注册声明。

Please see the other risks, uncertainties and factors set out under the heading 'Risk Factors' in the Company's annual report for the year ended December 31, 2025, which is available on the Company's issuer profile on SEDAR+ at

请参阅公司截至2025年12月31日止年度的年度报告中“风险因素”标题下详述的其他风险、不确定性和因素，该报告可在SEDAR+上的公司发行人档案中获取，网址为

www.sedarplus.ca

www.sedarplus.ca

and Edgar at

以及埃德加在

www.sec.gov/edgar

www.sec.gov/edgar

. Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward looking information is made. The Company does not undertake any obligation to update forward-looking statements, except as required by applicable securities laws.

本新闻稿中包含的任何前瞻性陈述均截至本新闻稿发布之日作出，并基于管理层在作出该等前瞻性信息当日所持有的信念、估计、预期和观点。除非适用证券法律另有要求，本公司不承担更新前瞻性陈述的任何义务。

Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement..

投资者不应过度依赖前瞻性陈述。本新闻稿中包含的前瞻性陈述明确受此警示性陈述的限定。

Logo:

标志：

https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

SOURCE IM Cannabis Corp.

来源 IM Cannabis Corp.

21

二十一

%

%

more press release views with

更多新闻稿浏览量，使用

Request a Demo

申请演示